Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
RMD Open|December 31, 2024
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot studyBas Dijkshoorn, Romy Hansildaar, Daisy Vedder, et al.
The Journal of Rheumatology|May 16, 2021
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare ProfessionalsJette A van Lint, Naomi T Jessurun, Sander W Tas, et al.
Arthritis Research & Therapy|July 14, 2021
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trialMarit Stockfelt, Anna-Carin Lundell, Merete Lund Hetland, et al.
Journal of Internal Medicine|April 7, 2026
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritisKristina Lend, Jos W R Twisk, Frieda A Koopman, et al.
Rheumatology (Oxford, England)|September 2, 2017
Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trialNicole P C Konijn, Lilian H D van Tuyl, Maarten Boers, et al.
Clinical and Experimental Rheumatology|May 24, 2016
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activityChamaida Plasencia, Gertjan Wolbink, Charlotte L M Krieckaert, et al.
Plos One|August 28, 2025
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritisTilia Selldén, Kerstin Andersson, Inger Gjertsson, et al.
Clinical Rheumatology|May 14, 2018
Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonanceP Stefan Biesbroek, Sjoerd C Heslinga, Peter M van de Ven, et al.
Annals of the Rheumatic Diseases|July 30, 2024
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trialKristina Lend, Jon Lampa, Leonid Padyukov, et al.
ACR Open Rheumatology|October 16, 2024
Circulating Baseline CXCR3+Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid ArthritisJulia M Scheffler, Christina Drevinge, Catharina Lindholm, et al.
Pageof 18